The online CME search engine.

Management Of Lipids / Gestational Diabetes / Glucose Control And Cardiovascular Risk

Provided by:

Course Description

The goal of this program is to improve lipid management in patients with type2 diabetes, improve screening for gestational diabetes, and prescribe glucose-lowering therapies that reduce risk for cardiovascular disease. After hearing and assimilating this program, the clinician will better be able to: 1.Prescribe statin therapy and proprotein convertase subtilisin/kexin type 9 inhibitors to lower low-density lipoprotein cholesterol in patients with type2 diabetes. 2.Identify interventions for reducing triglycerides and increasing high-density lipoprotein cholesterol. 3.Discuss benefits, drawbacks, and appropriate methods for early screening for gestational diabetes. 4.Summarize the effects of sodium glucose cotransporter-2 inhibitors and dipeptidyl peptide-4 inhibitors on risk for cardiovascular disease in patients with type2 diabetes. Online Resources American Diabetes Association: SGLT2 Inhibitors: The Latest New Kids on the Block http://care.diabetesjournals .org /content/38/3/352?rss=1 American Family Physician: ACC/AHA Release Updated Guideline on the Treatment of Blood Cholesterol to Reduce ASCVD Risk www. aafp .org /afp/2014/0815/p260.html National Diabetes Education Initiative: ­Diabetes Management Guidelines www. ndei .org /ADA-diabetes-management-guidelines-diabetes-in-pregnancy-GDM.aspx.html

Ratings and Reviews

To review this course, please login.

Please Review This Course

Overall Quality

Instructor

Usefulness

150 Characters Minimum

Submit
Course Information

Overall Quality

(0)

Instructor

(0)

Usefulness

(0)
Add to Transcript Write Review

Learning Format 6 Hours
Self-Study

Credit Type(s)
Cardiology